Trovagene (TROV) Misses Q3 EPS by 1c

Trovagene (NASDAQ: TROV) reported Q3 EPS of ($0.34), $0.01 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $89 thousand versus the consensus estimate of $320 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M